|
2026 Journal Article Su1603 AS SEVERE AS ASUC? CLINICAL FINDINGS FROM A LARGE COHORT OF MODERATELY SEVERE ACUTE ULCERATIVE COLITIS INPATIENTSEtchegaray, Amirah, Goetz, Naeman, Hanigan, Katherine, Tambakis, George, Phillips, Jennifer, Kumar, Rina, Radford-Smith, Graham, Walker, Gareth and Croft, Anthony (2026). Su1603 AS SEVERE AS ASUC? CLINICAL FINDINGS FROM A LARGE COHORT OF MODERATELY SEVERE ACUTE ULCERATIVE COLITIS INPATIENTS. Gastroenterology, 170 (6), S-1094. doi: 10.1016/s0016-5085(26)02810-6 |
|
2026 Journal Article Su1603 AS SEVERE AS ASUC? CLINICAL FINDINGS FROM A LARGE COHORT OF MODERATELY SEVERE ACUTE ULCERATIVE COLITIS INPATIENTSEtchegaray, Amirah, Goetz, Naeman, Hanigan, Katherine, Tambakis, George, Phillips, Jennifer, Kumar, Rina, Radford-Smith, Graham, Walker, Gareth and Croft, Anthony (2026). Su1603 AS SEVERE AS ASUC? CLINICAL FINDINGS FROM A LARGE COHORT OF MODERATELY SEVERE ACUTE ULCERATIVE COLITIS INPATIENTS. Gastrointestinal Endoscopy, 103 (5), S-1094. doi: 10.1016/s0016-5107(26)02741-0 |
|
2026 Journal Article P0339 Unmasking the faces of Severe Colitis: A data-driven approach to defining Ulcerative Colitis phenotypes and predicting clinical outcomesEtchegaray, A, Goetz, N, Okano, S, Hartel, G, Hanigan, K, Phillips, J, Kumar, R, Tambakis, G, Brown, A, Radford-Smith, G, Walker, G and Croft, A (2026). P0339 Unmasking the faces of Severe Colitis: A data-driven approach to defining Ulcerative Colitis phenotypes and predicting clinical outcomes. Journal of Crohn’s and Colitis, 20 (Supplement_1) jjaf231.520. doi: 10.1093/ecco-jcc/jjaf231.520 |
|
2026 Journal Article P0276 As severe as Acute Severe Ulcerative Colitis (ASUC)? Clinical findings from a large cohort of moderately severe acute Ulcerative Colitis inpatientsEtchegaray, A, Goetz, N, Hannigan, K, Phillips, J, Kumar, R, Tambakis, G, Radford-Smith, G, Walker, G and Croft, A (2026). P0276 As severe as Acute Severe Ulcerative Colitis (ASUC)? Clinical findings from a large cohort of moderately severe acute Ulcerative Colitis inpatients. Journal of Crohn’s and Colitis, 20 (Supplement_1) jjaf231.457. doi: 10.1093/ecco-jcc/jjaf231.457 |
|
2026 Journal Article P0776 The Likelihood of Early Infliximab Failure (LEIF) Score for Day Two Prediction of Infliximab Failure in Acute Ulcerative ColitisGoetz, N, Etchegaray, A, Tambakis, G, Phillips, J, Kumar, R, Brown, A, Radford-Smith, G, Walker, G, Croft, A and RBWH IBD Research Group (2026). P0776 The Likelihood of Early Infliximab Failure (LEIF) Score for Day Two Prediction of Infliximab Failure in Acute Ulcerative Colitis. Journal of Crohn’s and Colitis, 20 (Supplement_1) jjaf231.957. doi: 10.1093/ecco-jcc/jjaf231.957 |
|
2025 Journal Article Endosonographically confirmed Type III Choledochal Cyst Managed with Endoscopic Needle Knife DivisionEtchegaray, Amirah, Mudaliar, Sanjivan and Devereaux, Benedict (2025). Endosonographically confirmed Type III Choledochal Cyst Managed with Endoscopic Needle Knife Division. VideoGIE, 10 (8), 406-409. doi: 10.1016/j.vgie.2025.03.035 |
|
2025 Journal Article Ruptured hepatocellular carcinoma secondary to undiagnosed Hepatitis B in a young male Papua New Guinean patientBrough, David, Dahlenburg, Dominique, McNamara, Adam, Etchegaray, Amirah, Olive, Emily, Cavallucci, David, Bryant, Richard, Davis, Samuel, Foong, Samuel, Leggett, Barbara and O'Rourke, Nicholas (2025). Ruptured hepatocellular carcinoma secondary to undiagnosed Hepatitis B in a young male Papua New Guinean patient. HPB Cancer International, 3 (1), 1-5. doi: 10.64292/hpbci.160 |
|
2025 Journal Article Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s diseaseGilmore, Robert, Murali, Amrutha, Etchegaray, Amirah, Swe, Ei, An, Yoon-Kyo and Begun, Jakob (2025). Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease. Intestinal Research, 23 (4), 475-482. doi: 10.5217/ir.2024.00174 |
|
2025 Journal Article The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoringGilmore, Robert, Fernandes, Richard, Schildkraut, Tamar, Joshi, Riddhi, Lin, Lyman, Vorgin, Sara, Etchegaray, Amirah, Shanmuga Anandan, Aathavan, Tambakis, George, Loebenstein, Moshe, An, Yoon-Kyo, Begun, Jakob and Wright, Emily K (2025). The durability of anti-TNF therapy for Crohn’s Disease is higher in anti-TNF naïve patients and increases with proactive therapeutic drug monitoring. Crohn's and Colitis 360, 7 (2) otaf028, 1-9. doi: 10.1093/crocol/otaf028 |
|
2025 Journal Article Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort studyEtchegaray, Amirah, Mudaliar, Sanjivan, Ryan, Kimberley, Hay, Karen, Hwang, Jason, Devereaux, Benedict, Appleyard, Mark and Grimpen, Florian (2025). Safety, efficacy and post-endoscopic retrograde cholangiopancreatography survival in nonagenarians: a retrospective cohort study. Internal Medicine Journal, 55 (3), 435-443. doi: 10.1111/imj.16652 |
|
2025 Journal Article Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case seriesEtchegaray, Amirah, Tambakis, George, Kumar, Rina, Croft, Anthony, Radford-Smith, Graham and Walker, Gareth J. (2025). Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series. Therapeutic Advances in Gastroenterology, 18 17562848251323511, 1-14. doi: 10.1177/17562848251323511 |
